83 FR 46164 - Board Meeting; 77 K St. NE, Washington, DC; 10th Floor; September 17, 2018; 8:30 a.m.

FEDERAL RETIREMENT THRIFT INVESTMENT BOARD

Federal Register Volume 83, Issue 177 (September 12, 2018)

Page Range		46164-46164
FR Document		2018-19833

Federal Register, Volume 83 Issue 177 (Wednesday, September 12, 2018)

[Federal Register Volume 83, Number 177 (Wednesday, September 12, 2018)]
[Notices]
[Page 46164]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-19833]


=======================================================================
-----------------------------------------------------------------------

FEDERAL RETIREMENT THRIFT INVESTMENT BOARD


Board Meeting; 77 K St. NE, Washington, DC; 10th Floor; September 
17, 2018; 8:30 a.m.

Open Session

1. Approval of the Minutes of the August 27, 2018 Board Meeting
2. Monthly Reports
    (a) Participant Activity
    (b) Investment Policy
    (c) Legislative Report
3. FY 19 Budget Review and Approval
4. Vendor Risk Management Update
5. Capital Market and L Fund Update
6. IT Update

Closed Session

    Information covered under 5 U.S.C. 552b(c)(4) and (c)(9)(B).

CONTACT PERSON FOR MORE INFORMATION: Kimberly Weaver, Director, Office 
of External Affairs, (202) 942-1640.

    Dated: September 7, 2018.
Dharmesh Vashee,
Deputy General Counsel, Federal Retirement Thrift Investment Board.
[FR Doc. 2018-19833 Filed 9-11-18; 8:45 am]
BILLING CODE 6760-01-P

46164 Federal Register / Vol. 83, No. 177 / Wednesday, September 12, 2018 / Notices

reports that detail funding provisions of EGRRCPA. The Board has DEPARTMENT OF HEALTH AND
vulnerabilities. revised the FR 2052a to provide that HUMAN SERVICES
Legal authorization and respondents are permitted to report
confidentiality: The Board’s Legal investment grade municipal obligations Food and Drug Administration
Division has determined that the FR as HQLA, consistent with EGRRCPA [Docket No. FDA–2011–N–0908]
2052a is authorized pursuant to section and the Liquidity IFR. In order for the
5 of the Bank Holding Company Act (12 FR 2052a to reflect section 403 of Agency Information Collection
U.S.C. 1844), section 8 of the EGRRCPA, which became effective Activities; Submission for Office of
International Banking Act (12 U.S.C. Management and Budget Review;
immediately when EGRRCPA was
3106), and section 165 of the Dodd- Comment Request; Guidance for
signed on May 24, 2018, the Board
Frank Wall Street Reform and Consumer Clinical Trial Sponsors: Establishment
Protection Act (Dodd-Frank Act) (12 cannot comply with the normal
clearance process and still receive the and Operation of Clinical Trial Data
U.S.C. 5365) and are mandatory. Section
June 30, 2018, financial data in a timely Monitoring Committees
5(c) of the Bank Holding Company Act
authorizes the Board to require BHCs to manner. Therefore, the Board has AGENCY: Food and Drug Administration,
submit reports to the Board regarding determined that the revision to the FR HHS.
their financial condition. Section 8(a) of 2052a described above must be
ACTION: Notice.
the International Banking Act subjects instituted quickly and public
FBOs to the provisions of the Bank participation in the approval process SUMMARY: The Food and Drug
Holding Company Act. Section 165 of would substantially interfere with the Administration (FDA) is announcing
the Dodd-Frank Act requires the Board Board’s ability to perform its statutory that a proposed collection of
to establish prudential standards for obligations arising from EGRRCPA. information has been submitted to the
certain BHCs and FBOs, which include Office of Management and Budget
Board of Governors of the Federal Reserve
liquidity requirements. (OMB) for review and clearance under
System, September 6, 2018.
Financial institution information the Paperwork Reduction Act of 1995.
required by the FR 2052a is collected as Michele Taylor Fennell,
DATES: Fax written comments on the
part of the Board’s supervisory process. Assistant Secretary of the Board.
collection of information by October 12,
Therefore, such information is entitled [FR Doc. 2018–19675 Filed 9–11–18; 8:45 am]
2018.
to confidential treatment under BILLING CODE 6210–01–P
Exemption 8 of the Freedom of ADDRESSES: To ensure that comments on
Information Act (FOIA) (5 U.S.C. the information collection are received,
552(b)(8)). In addition, the institution OMB recommends that written
information provided by each comments be faxed to the Office of
FEDERAL RETIREMENT THRIFT Information and Regulatory Affairs,
respondent would not be otherwise INVESTMENT BOARD
available to the public and its disclosure OMB, Attn: FDA Desk Officer, Fax: 202–
could cause substantial competitive 395–7285, or emailed to oira_
Board Meeting; 77 K St. NE,
harm. Accordingly, it is entitled to submission@omb.eop.gov. All
Washington, DC; 10th Floor;
confidential treatment under the comments should be identified with the
September 17, 2018; 8:30 a.m. OMB control number 0910–0581. Also
authority of exemption 4 of the FOIA (5
U.S.C. 552(b)(4)), which protects from Open Session include the FDA docket number found
disclosure trade secrets and commercial in brackets in the heading of this
or financial information. 1. Approval of the Minutes of the document.
Current Actions: The Economic August 27, 2018 Board Meeting FOR FURTHER INFORMATION CONTACT:
Growth, Regulatory Relief, and 2. Monthly Reports JonnaLynn Capezzuto, Office of
Consumer Protection Act (EGRRCPA), Operations, Food and Drug
(a) Participant Activity
enacted on May 24, 2018, amended Administration, Three White Flint
various provisions of banking law to (b) Investment Policy North, 10A–12M, 11601 Landsdown St.,
eliminate or reduce statutory and (c) Legislative Report North Bethesda, MD 20852, 301–796–
regulatory requirements on certain 3794, PRAStaff@fda.hhs.gov.
3. FY 19 Budget Review and Approval
banking organizations. Section 403 of
4. Vendor Risk Management Update SUPPLEMENTARY INFORMATION: In
EGRRCPA provides that the federal
compliance with 44 U.S.C. 3507, FDA
banking agencies shall treat certain 5. Capital Market and L Fund Update has submitted the following proposed
municipal obligations as ‘‘high quality
6. IT Update collection of information to OMB for
liquid assets’’ (HQLA) for purposes of
their liquidity regulations, and must review and clearance.
Closed Session
amend those regulations to reflect this Guidance for Clinical Trial Sponsors:
new treatment within 90 days of the Information covered under 5 U.S.C. Establishment and Operation of
enactment of EGRRCPA. The federal 552b(c)(4) and (c)(9)(B). Clinical Trial Data Monitoring
banking agencies, on August 22, 2018, CONTACT PERSON FOR MORE INFORMATION: Committees
issued an interim final rule 1 amending Kimberly Weaver, Director, Office of OMB Control Number 0910–0581—
their liquidity regulations (the
External Affairs, (202) 942–1640. Extension
‘‘Liquidity IFR’). The current FR 2052a
daltland on DSKBBV9HB2PROD with NOTICES

instructions are inconsistent with the Dated: September 7, 2018. Sponsors are required to monitor
Dharmesh Vashee, studies evaluating new drugs, biologics,
1 Press Release, Board of Governors of the Federal
Deputy General Counsel, Federal Retirement and devices (21 CFR 312.50 and 312.56
Reserve System, Agencies issue final rule regarding for drugs and biologics, and 21 CFR
Thrift Investment Board.
the treatment of certain municipal securities as
high-quality liquid assets (August 22, 2018), [FR Doc. 2018–19833 Filed 9–11–18; 8:45 am] 812.40 and 812.46 for devices). Various
available at https://www.federalreserve.gov/ individuals and groups play different
BILLING CODE 6760–01–P
newsevents/pressreleases/bcreg20180822a.htm. roles in clinical trial monitoring. One

VerDate Sep<11>2014 18:41 Sep 11, 2018 Jkt 244001 PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 E:\FR\FM\12SEN1.SGM 12SEN1

Document Created: 2018-09-12 02:06:37
Document Modified: 2018-09-12 02:06:37

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
FR Citation		83 FR 46164